3-[(3-Chloropropyl)thio]-4-methyl-5-[4-(trifluoromethyl)phenyl]-4H-1,2,4-triazole → 3-methyl-7-[3-({4-methyl-5-[4-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-3-yl}thio)propyl]-6,7,8,9-tetrahydro-5H-isoxazolo[4,5-h][3]benzazepine hydrochloride
Reaction equation
[CH3:1][C:2]1[C:15]2[C:5](=[CH:6][C:7]3[CH2:13][CH2:12][NH:11][CH2:10][CH2:9][C:8]=3[CH:14]=2)[O:4][N:3]=1.[Cl:16][CH2:17][CH2:18][CH2:19][S:20][C:21]1[N:25]([CH3:26])[C:24]([C:27]2[CH:32]=[CH:31][C:30]([C:33]([F:36])([F:35])[F:34])=[CH:29][CH:28]=2)=[N:23][N:22]=1>>[ClH:16].[CH3:1][C:2]1[C:15]2[C:5](=[CH:6][C:7]3[CH2:13][CH2:12][N:11]([CH2:17][CH2:18][CH2:19][S:20][C:21]4[N:25]([CH3:26])[C:24]([C:27]5[CH:32]=[CH:31][C:30]([C:33]([F:36])([F:34])[F:35])=[CH:29][CH:28]=5)=[N:23][N:22]=4)[CH2:10][CH2:9][C:8]=3[CH:14]=2)[O:4][N:3]=1Participants
3
Reactant 2
Product 1
Procedure
The title compound was prepared in analogy to General Procedure 1 from 3-methyl-6,7,8,9-tetrahydro-5H-isoxazolo[4,5-h][3]benzazepine (0.12 mmol) and 3-[(3-chloropropyl)thio]-4-methyl-5-[4-(trifluoromethyl)phenyl]-4H-1,2,4-triazole (0.14 mmol) and was obtained as a faint yellow slightly hygroscopic solid (0.01 mmol).
Sources & evidence
- ORD record
- ord-4e058e8f50124026a5022463a8c40cec
- Source dataset
- uspto-grants-2011_08
- Patent number
- US07989444B2
Reaction notes
Loading…